A Randomized, Open-label Phase Ib Trial of Fruquintinib "4mg Once Daily Continuous" Versus "5mg Once Daily 3wks on/1wk Off " in Patients With Metastatic Colorectal Carcinoma as 3rd Therapy

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 01 Mar 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

10 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
03 Jun 2014 Results for the first stage presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
12 Nov 2013 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com